ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

期刊名

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

ASSAY DRUG DEV TECHN

ISSN / eISSN

1540-658X / 1557-8127

目标和范围

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:
-Assay design, target development, and high-throughput technologies-
Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-
Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-
Approaches to assays configured for gene families, inherited, and infectious diseases-
Assays and strategies for adapting model organisms to drug discovery-
The use of stem cells as models of disease-
Translation of phenotypic outputs to target identification-
Exploration and mechanistic studies of the technical basis for assay and screening artifacts

研究方向

生化研究方法

药学

CiteScore

3.70 查看趋势图

CiteScore 学科排名

类别	分区	排名
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery	Q3	#97/156
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine	Q3	#122/171

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
BIOCHEMICAL RESEARCH METHODS - SCIE	Q4
PHARMACOLOGY & PHARMACY - SCIE	Q4

H-index

52

出版国家或地区

UNITED STATES

出版商

Mary Ann Liebert Inc.

出版周期

Bimonthly

出版年份

2002

年文章数

27

Open Access

NO

通讯方式

MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801